CELEMICS' News & Events

View the various news of Celemics

Celemics, South Dakota State University, announce partnership for the development of Hybridization NGS-based Multiple Swine Pathogen Co-Detection Panel

GenomeWebEINPRESSWIRE

  • DateJul. 07 2021

Celemics, South Dakota State University, announce partnership for the development of Hybridization NGS-based Multiple Swine Pathogen Co-Detection Panel.

 

- The proposed methods are seen as a revolutionary step towards preventing swine respiratory diseases 

 

                                      

 

July 07, 2021, Seoul, Korea: Celemics, Inc.(www.celemics.com) has partnered with South Dakota State University’s Animal Disease Research and Diagnostic Laboratory (ADRDL) to create the first-ever hybridization-based
next generation sequencing (NGS) kit to detect viral and bacterial swine respiratory pathogens.

 

Most current diagnostic technologies are based on culture or qPCR. These widely used methods come with a great amount of limitations in terms of detecting a wide range of pathogens. The new and proposed breakthrough technique
can make it possible to detect several viral and bacterial pathogens at once. 

 

Celemics Inc. is known for its innovative and ground-breaking research. It was the need of the hour to alter the paradigm of medicine for swine respiratory diagnosis and treatment. It is hoped that their much-welcomed partnership with
the esteemed South Dakota State University will bring revolutionary methods for early detection and cure to the industry.

Until this point in time, the genetic characterization, including whole genome sequence information for viral pathogens and multi-locus sequencing typing (MLST) analysis for bacterial pathogens, is attained through pathogen detection methods.
This joint venture of research between the two reputed names has given them hope for improved overall herd health outcomes. The technology aims to overcome the shortfalls of modern diagnostics by enabling highly multiplexed detection
and sequence characterization. 

Not only would this be more efficient but considerably cost-effective in comparison to the existing practices.
 

We spoke to Mr. Benjamin Hause, Assistant Professor in the Department of Veterinary and Biomedical Sciences, about this promising prospect:

“We are pleased to partner with Celemics on developing and bringing this exciting new technology to the swine industry,” 'Celemics’ hybridization panel represents a large leap forward in our ability to detect and concurrently
genetically characterize swine pathogens.
While we focus on the most significant pathogens such as porcine reproductive and respiratory syndrome virus and influenza A virus, clinical disease is often the end result of co-infections with a number of viruses and bacteria.
Celemics’ technology will enable comprehensive pathogen screening that will allow better herd management and improved swine health.”

The technology aims to overcome the shortfalls of modern diagnostics by enabling highly multiplexed detection and sequence characterization. Not only would this be more efficient but considerably cost-effective in comparison to the existing practices.

 

The kit results from years of remarkable research and comprises more than 50 different viral and bacterial swine pathogens. All of these sequences have been carefully chosen based on the study of patterns that are relevant to swine health
and include domestically critical species such as the porcine reproductive and respiratory syndrome virus (PRRSV) and influenza A virus, along with foreign viruses such as African swine fever virus (ASFV) and foot and mouth disease virus.

“With this new partnership, we hope to provide clinicians, veterinarians, and livestock breeders with a powerful, comprehensive tool for swine disease detection and prevention,” said co-CEO and founder of Celemics, Dr. Hyoki Kim. 

 

Through the advantages of hybridization NGS, we hope to provide a kit capable of revolutionizing clinical research and diagnostics and hope to effectively combat future swine disease epidemics.